An update on the treatment of Sydenham's chorea: the evidence for established and evolving interventions.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 3002660)

Published in Ther Adv Neurol Disord on September 01, 2010

Authors

Kathleen G Walker1, Jo M Wilmshurst

Author Affiliations

1: K. G. Walker, S25/26 Neurology OPD, Red Cross Children's Hospital, Klipfontein Road, Rondebosch, 7700 Western Cape, South Africa.

Associated clinical trials:

NCT 00615797

Articles cited by this

Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08

Acute rheumatic fever. Lancet (2005) 5.58

Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation (2009) 3.34

Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med (1976) 2.98

Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA (1994) 2.84

Towards a uniform plan for the control of rheumatic fever and rheumatic heart disease in Africa--the Awareness Surveillance Advocacy Prevention (A.S.A.P.) Programme. S Afr Med J (2006) 1.59

Corticosteroid treatment in patients with Sydenham's chorea. Pediatr Neurol (2005) 1.50

Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol (2005) 1.41

Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham's chorea: clinical follow-up of 18 patients. Arq Neuropsiquiatr (2002) 1.32

Sydenham chorea: an update. Neurology (1980) 1.14

Sydenham's chorea: a clinical follow-up of 65 patients. J Child Neurol (2007) 1.12

Sydenham's chorea: clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens. Brain Dev (2002) 1.11

Intramuscular penicillin is more effective than oral penicillin in secondary prevention of rheumatic fever--a systematic review. S Afr Med J (2003) 1.09

Beneficial use of immunoglobulins in the treatment of Sydenham chorea. Eur J Pediatr (2010) 1.03

Clinical profile of acute rheumatic fever in children. J Trop Pediatr (1989) 1.02

THE NATURAL HISTORY OF SYDENHAM'S CHOREA. REVIEW OF THE LITERATURE AND LONG-TERM EVALUATION WITH EMPHASIS ON CARDIAC SEQUELAE. Am J Med (1965) 1.02

Sydenham's Chorea. Curr Treat Options Neurol (2008) 1.00

Valproic acid in Sydenham's chorea. Br Med J (Clin Res Ed) (1981) 0.97

Rheumatic chorea in northern Australia: a clinical and epidemiological study. Arch Dis Child (1999) 0.95

Pediatric movement disorders: an update. Curr Opin Neurol (2008) 0.94

Sydenham's chorea, and its complications affecting the nervous system. Brain Dev (2008) 0.94

Rheumatic fever and its management. BMJ (2006) 0.94

The prevalence of neuropsychiatric disorders in Sydenham's chorea. Pediatr Neurol (2010) 0.92

Are all recurrences of "pure" Sydenham chorea true recurrences of acute rheumatic fever? J Pediatr (1985) 0.89

Sydenham's chorea: a new look at an old disease. Br J Clin Pract (1993) 0.88

Chronic dopaminergic sensitivity after Sydenham's chorea. Neurology (1983) 0.88

Randomized double-blind study with prednisone in Sydenham's chorea. Pediatr Neurol (2006) 0.87

Resurgence of rheumatic fever in the United States. The changing picture of a preventable illness. Postgrad Med (1992) 0.86

Corticosteroids in the treatment of Sydenham's chorea. Arch Neurol (1978) 0.83

Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am J Psychiatry (1998) 0.83

Neuropsychiatric aspects of Sydenham's chorea: a comprehensive review. J Clin Psychiatry (1996) 0.83

Successful treatment of rheumatic chorea with carbamazepine. Pediatr Neurol (2000) 0.83

On Paralytic Chorea. Br Med J (1881) 0.82

Neuropsychiatric movement disorders following streptococcal infection. Dev Med Child Neurol (2005) 0.82

Treatment of acute Sydenham's chorea with methyl-prednisolone pulse-therapy. Parkinsonism Relat Disord (2005) 0.81

Effectiveness of sodium valproate in the treatment of Sydenham's chorea. Neurology (1990) 0.81

Acute rheumatic fever. Lancet (2005) 0.80

Pimozide treatment of Sydenham's chorea. Neurology (1990) 0.79

Successful treatment of refractory Sydenham's chorea with pimozide. J Neurol Neurosurg Psychiatry (1985) 0.78

Choreiform movements associated with the use of valproate. Arch Neurol (1994) 0.78

Valproic acid in the treatment of Sydenham chorea. Pediatr Neurol (1989) 0.77

Sodium valproate and baclofen for Sydenham's chorea. S Afr Med J (1983) 0.77

Carbamazepine-induced choreoathetoid dyskinesias. J Neurol Neurosurg Psychiatry (1982) 0.77

Treatment of Sydenham's chorea with haloperidol. Dev Med Child Neurol (1973) 0.76

Sydenham's chorea. Clinical and therapeutic update. Adv Exp Med Biol (1997) 0.76

Sydenham's chorea may be a risk factor for drug induced parkinsonism. J Neurol Neurosurg Psychiatry (2003) 0.76

Sydenham's chorea-clinical characteristics of nine patients. Int J Cardiol (2004) 0.76

Sodium valproate in Sydenham's chorea. Indian Pediatr (1992) 0.76

Efficacy of valproic acid in the treatment of Sydenham's chorea. J Child Neurol (1988) 0.76

Sydenham's chorea--clinical and therapeutic update 320 years down the line. S Afr Med J (2006) 0.76

Sodium valproate in Sydenham's chorea. Neurology (1985) 0.76

[Sydenham's chorea in Tunisia: a report on 65 cases (author's transl)]. Ann Med Interne (Paris) (1979) 0.76

Rheumatic fever and rheumatic heart disease among 56,8000 inhabitants in southeast Teheran from 1972-1974. Acta Trop (1976) 0.76

Sodium valproate in the treatment of Sydenham's chorea. Indian J Pediatr (2010) 0.76

[Sydenham's chorea in children]. Arch Pediatr (1999) 0.76

Articles by these authors

Progressive multifocal leukoencephalopathy after initiation of highly active antiretroviral therapy in a child with advanced human immunodeficiency virus infection: a case of immune reconstitution inflammatory syndrome. Pediatr Infect Dis J (2004) 0.94

Treatment of sydenham chorea with intravenous immunoglobulin. J Child Neurol (2011) 0.91

Neurologic and neurobehavioral sequelae in children with human immunodeficiency virus (HIV-1) infection. J Child Neurol (2011) 0.90

Giant congenital melanocytic nevi in a patient with brain structural malformations and multiple lipomatosis. J Child Neurol (2002) 0.85

The diagnostic difficulties of complex glycerol kinase deficiency. J Child Neurol (2010) 0.83

A novel ACTA1 mutation resulting in a severe congenital myopathy with nemaline bodies, intranuclear rods and type I fibre predominance. Neuromuscul Disord (2010) 0.81

RyR1 deficiency in congenital myopathies disrupts excitation-contraction coupling. Hum Mutat (2013) 0.81

Prevalence of seizures in children infected with human immunodeficiency virus. J Child Neurol (2012) 0.80

The characteristics of juvenile myasthenia gravis among South Africans. S Afr Med J (2012) 0.79

Intellectual and behavioral functioning in a South african cohort of boys with duchenne muscular dystrophy. J Child Neurol (2011) 0.79

Gillespie syndrome: two further cases. J Child Neurol (2006) 0.78

Spinal muscular atrophy with congenital fractures: postmortem analysis. J Child Neurol (2002) 0.78

Hydatid disease of the spine in South African children. J Child Neurol (2003) 0.77

Acquired demyelinating disorders of childhood in the Western Cape, South Africa. J Child Neurol (2009) 0.77

Sydenham's chorea--clinical and therapeutic update 320 years down the line. S Afr Med J (2006) 0.76

Epilepsy South Africa: Turning obstacles into true potential. Epilepsia (2014) 0.76

Genetic testing for spinal muscular atrophy. S Afr Med J (2006) 0.75

Subacute sclerosing panencephalitis in South African children following the measles outbreak between 2009 and 2011. S Afr Med J (2015) 0.75

The Keilah Foundation: making the ketogenic diet viable for children in Africa. Epilepsia (2014) 0.75

Leaving the party -- withdrawal of South African essential medicines. S Afr Med J (2006) 0.75

Child neurology in Africa. Semin Pediatr Neurol (2014) 0.75

Markers of susceptibility to acute rheumatic fever: the B-cell antigen D8/17 is not robust as a marker in South Africa. Cardiol Young (2011) 0.75

Hemiatrophy of the spinal cord in a patient with mucopolysaccharidosis type IIIB. J Child Neurol (2010) 0.75

Congenital cervical spinal cord lesions: pathogenesis, management, and outcome. J Child Neurol (2007) 0.75

Access to parenteral phenobarbitone. S Afr Med J (2008) 0.75